Press release
September 4, 2026
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
Veraxa Biotech AG - Post de-SPAC (VRXA)
Mr. Willener brings more than three decades of global capital markets and corporate finance experience to support advancement of the Company’s pipeline of potential best-in-class therapies led by its BiTAC® platform Zurich, Switzerland, Sept. 04, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ: